Genetic testing company Myriad Genetics (NASDAQ:MYGN) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose ...

The results, published May 5 in Nature Genetics, offer a new way to understand the molecular roots of cancer — an especially ...

Myriad Genetics (NASDAQ:MYGN) reported first-quarter fiscal 2026 revenue of $200.4 million, reflecting 2% year-over-year ...

Cancer isn't a static target. Its genetic profile can change. So even with the newer targeted therapies, a patient's care ...

Despite advances, whole genome sequencing — and with it the promise of early, life-altering therapies — still isn’t a routine part of care for most newborns. Many babies enter the world with silent ...

Opus Genetics Inc. (NASDAQ:IRD) is one of the best performing NASDAQ stocks according to Wall Street analysts.

During the early stages of a pandemic, viruses tend to evolve in ways that enhance their ability to reproduce and spread, ...

Genetics isn’t just for scientists in labs — it’s the story of who we are, how we function, and why we’re unique. From the way traits are inherited to how DNA folds in 3D to control gene activity, ...

An individual’s genetics and their environment both shape their personality. However, opinions differ on the degree to which each of these factors influences personality, and how they contribute to ...

Vietnam’s livestock sector holds a strong position on the global map. However, it remains heavily dependent on imported ...